Advertisement
UK markets close in 7 hours 48 minutes
  • FTSE 100

    8,066.06
    +42.19 (+0.53%)
     
  • FTSE 250

    19,659.68
    +60.29 (+0.31%)
     
  • AIM

    750.58
    +1.40 (+0.19%)
     
  • GBP/EUR

    1.1573
    -0.0015 (-0.13%)
     
  • GBP/USD

    1.2365
    +0.0015 (+0.12%)
     
  • Bitcoin GBP

    53,508.82
    +22.39 (+0.04%)
     
  • CMC Crypto 200

    1,397.48
    -17.28 (-1.22%)
     
  • S&P 500

    5,010.60
    +43.37 (+0.87%)
     
  • DOW

    38,239.98
    +253.58 (+0.67%)
     
  • CRUDE OIL

    82.22
    +0.32 (+0.39%)
     
  • GOLD FUTURES

    2,321.80
    -24.60 (-1.05%)
     
  • NIKKEI 225

    37,552.16
    +113.55 (+0.30%)
     
  • HANG SENG

    16,814.03
    +302.34 (+1.83%)
     
  • DAX

    17,993.60
    +132.80 (+0.74%)
     
  • CAC 40

    8,061.12
    +20.76 (+0.26%)
     

Here's Why Investors Should Hold on to MAXIMUS (MMS) Stock

A prudent investment decision involves buying stocks that have solid prospects and selling those that carry risks. At times, it is rational to hold certain stocks that have enough potential but are weighed down by tough market conditions.

We believe that MAXIMUS, Inc. MMS, with Growth Score of A and a market cap of $4.9 billion, is a stock that investors should retain in their portfolio. Shares of the company have gained 18% year to date.

Factors that Bode Well

MAXIMUS’ business process management expertise and ability to deliver cost-effective, efficient and high-scale solutions position it as a lucrative partner to governments. The company maintains solid relationship with governments and long-term contracts provide it predictable recurring revenue streams. MAXIMUS continuously seeks long-term relationships with clients in both existing and adjacent markets. It is also focused on digital transformation and expansion of foothold in clinical services.

ADVERTISEMENT

Increased longevity and more complex health needs have boosted the demand for government social benefit and safety-net programs. This should continue driving the need for the company’s services.

The 2018 acquisition of General Dynamics Information Technology's citizen engagement centers brought in additional cost-plus contracts, enhanced technology and added operational capabilities.

Hurdles on the Way

Low unemployment rates across geographies, especially in Australia and UK keeps MAXIMUS’ outside the United States segment under pressure. This is due to lower case load volumes on the company’s welfare-to-work contracts. Revenues from the segment declined 14.3% in fiscal 2019. The segment’s gross profit margin and operating income margin declined 130 basis points (bps) and 240 bps, respectively.

Zacks Rank and Stocks to Consider

MAXIMUS currently carries a Zacks Rank #3 (Hold).

Some better-ranked stocks in the broader Zacks Business Services sector are Global Payments GPN, Mastercard MA and Cardtronics CATM. While Global Payments and Cardtronics sport a Zacks Rank #1 (Strong Buy), Mastercard carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Long-term expected EPS (three to five years) growth rate for Global Payments, Mastercard and Cardtronics is 17%, 16% and 4%, respectively.

Today's Best Stocks from Zacks

Would you like to see the updated picks from our best market-beating strategies? From 2017 through Q3 2019, while the S&P 500 gained +39.6%, five of our strategies returned +51.8%, +57.5%, +96.9%, +119.0%, and even +158.9%.

This outperformance has not just been a recent phenomenon. From 2000 – Q3 2019, while the S&P averaged +5.6% per year, our top strategies averaged up to +54.1% per year.

See their latest picks free >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Cardtronics PLC (CATM) : Free Stock Analysis Report
 
Mastercard Incorporated (MA) : Free Stock Analysis Report
 
Global Payments Inc. (GPN) : Free Stock Analysis Report
 
Maximus, Inc. (MMS) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research